Jacobs & CO Becton Dickinson & CO Transaction History

Jacobs & CO

$983 Million
Q4 2024

A detailed history of Jacobs & CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Jacobs & CO holds 31,052 shares of BDX stock, worth $6.98 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

31,052

Previous 43,812 29.12%

Holding current value

$6.98 Million

Previous $10.6 Million 33.31%

% of portfolio

0.72%

Previous 1.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 10, 2025	SELL	$220.02 - $243.75 $2.81 Million - $3.11 Million	-12,760 Reduced 29.12%	31,052 $7.04 Million
Q3 2024 Oct 01, 2024	SELL	$221.47 - $242.41 $906,919 - $992,668	-4,095 Reduced 8.55%	43,812 $10.6 Million
Q2 2024 Jul 12, 2024	SELL	$225.07 - $246.17 $7,202 - $7,877	-32 Reduced 0.07%	47,907 $11.2 Million
Q1 2024 Apr 12, 2024	BUY	$233.45 - $247.73 $106,453 - $112,964	456 Added 0.96%	47,939 $11.9 Million
Q4 2023 Jan 17, 2024	BUY	$232.24 - $267.23 $8,592 - $9,887	37 Added 0.08%	47,483 $11.6 Million
Q3 2023 Oct 13, 2023	SELL	$254.9 - $283.59 $305,370 - $339,740	-1,198 Reduced 2.46%	47,446 $12.3 Million
Q2 2023 Jul 11, 2023	SELL	$238.39 - $265.32 $423,380 - $471,208	-1,776 Reduced 3.52%	48,644 $12.8 Million
Q1 2023 Apr 17, 2023	SELL	$229.71 - $259.35 $45,942 - $51,870	-200 Reduced 0.4%	50,420 $12.5 Million
Q4 2022 Jan 13, 2023	SELL	$218.29 - $256.91 $17,463 - $20,552	-80 Reduced 0.16%	50,620 $12.9 Million
Q3 2022 Oct 11, 2022	BUY	$51.03 - $264.23 $1,377 - $7,134	27 Added 0.05%	50,700 $11.3 Million
Q2 2022 Jul 19, 2022	SELL	$234.74 - $275.42 $395,302 - $463,807	-1,684 Reduced 3.22%	50,673 $12.5 Million
Q1 2022 Apr 14, 2022	SELL	$243.64 - $270.48 $210,261 - $233,424	-863 Reduced 1.62%	52,357 $13.9 Million
Q4 2021 Jan 21, 2022	BUY	$230.08 - $250.94 $105,606 - $115,181	459 Added 0.87%	53,220 $13.4 Million
Q3 2021 Oct 13, 2021	BUY	$232.72 - $256.47 $567,371 - $625,273	2,438 Added 4.84%	52,761 $13 Million
Q2 2021 Jul 15, 2021	BUY	$232.65 - $254.58 $484,842 - $530,544	2,084 Added 4.32%	50,323 $12.2 Million
Q1 2021 Apr 05, 2021	BUY	$232.09 - $256.88 $388,982 - $430,530	1,676 Added 3.6%	48,239 $11.7 Million
Q4 2020 Jan 12, 2021	BUY	$221.92 - $245.94 $183,971 - $203,884	829 Added 1.81%	46,563 $11.7 Million
Q3 2020 Dec 03, 2020	BUY	$215.77 - $276.76 $400,900 - $514,220	1,858 Added 4.23%	45,734 $10.6 Million
Q2 2020 Jul 09, 2020	BUY	$219.9 - $263.41 $1.6 Million - $1.92 Million	7,295 Added 19.94%	43,876 $10.5 Million
Q1 2020 Apr 13, 2020	BUY	$195.69 - $279.01 $102,737 - $146,480	525 Added 1.46%	36,581 $8.41 Million
Q4 2019 Jan 29, 2020	BUY	$236.45 - $266.82 $964,479 - $1.09 Million	4,079 Added 12.76%	36,056 $9.81 Million
Q3 2019 Nov 04, 2019	SELL	$230.58 - $256.08 $57,875 - $64,276	-251 Reduced 0.78%	31,977 $8.09 Million
Q2 2019 Aug 01, 2019	BUY	$217.4 - $246.08 $334,578 - $378,717	1,539 Added 5.01%	32,228 $8.12 Million
Q1 2019 Apr 29, 2019	SELL	$206.05 - $248.17 $106,115 - $127,807	-515 Reduced 1.65%	30,689 $7.66 Million
Q4 2018 Feb 07, 2019	BUY	$204.73 - $257.93 $9,008 - $11,348	44 Added 0.14%	31,204 $7.03 Million
Q3 2018 Oct 23, 2018	SELL	$233.07 - $256.0 $50,110 - $55,040	-215 Reduced 0.69%	31,160 $8.13 Million
Q2 2018 Jul 19, 2018	BUY	$208.1 - $233.85 $24,555 - $27,594	118 Added 0.38%	31,375 $7.52 Million
Q1 2018 Apr 30, 2018	SELL	$205.46 - $240.27 $54,035 - $63,191	-263 Reduced 0.83%	31,257 $6.77 Million
Q4 2017 Feb 09, 2018	SELL	$189.0 - $222.64 $122,850 - $144,716	-650 Reduced 2.02%	31,520 $6.75 Million
Q3 2017 Nov 14, 2017	BUY	$186.89 - $198.9 $6.01 Million - $6.4 Million	32,170	32,170 $6.3 Million

Others Institutions Holding BDX

# of Institutions

1,799

Shares Held

260M

Call Options Held

1.28M

Put Options Held

1.12M

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.1B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.

Account